The case for routine use of adjuvant therapy in pancreatic cancer

Journal of Surgical Oncology

Volumn 95, Issue 7, 2007, Pages 597-603

  Kennedy, Eugene P ^a   Yeo, Charles J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adjuvant therapy; Chemoradiotherapy; Pancreatic cancer

Indexed keywords

ALPHA INTERFERON; CANCER VACCINE; CISPLATIN; DIPYRIDAMOLE; ERLOTINIB; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; MITOMYCIN C; ANTINEOPLASTIC AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADJUVANT CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; IMMUNOTHERAPY; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; UNSPECIFIED SIDE EFFECT; ADENOCARCINOMA; ADJUVANT THERAPY; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; MORTALITY; MULTIMODALITY CANCER THERAPY; PANCREAS RESECTION; PANCREAS TUMOR; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CANCER VACCINES; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FLUOROURACIL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEUCOVORIN; PANCREATECTOMY; PANCREATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE;

EID: 34347384246     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20719     Document Type: Review

References (35)

1. Kennedy EP, Yeo CJ: Pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma. Surg Oncol Clin N Am 2007;16: (In press).
2. Sohn TA, Yeo CJ, Cameron JL, et al.: Resected adenocarcinoma of the pancreas-616 patients: Results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;4:567-579.
3. Kalser MH, Ellenberg SS: Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899-903.
4. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987;59:2006-2010.
5. Whittington R, Bryer MP, Haller DG, et al.: Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1991;21:1137-1143.
6. Foo ML, Gunderson LL, Nagorney DM, et al.: Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/-5 fluorouracil. Int J Radiat Oncol Biol Phys 1993;26:483-489.
7. Spitz FR, Abbruzzese JL, Lee JE, et al.: Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997;15:928-937.
8. Yeo CJ, Abrams RA, Grochow LB, et al.: Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 1997;225:621-633; discussion 633-636.
9. Demeure MJ, Doffek KM, Komorowski RA, et al.: Molecular metastases in stage 1 pancreatic cancer: Improved survival with adjuvant chemoradiation. Surgery 1998;124:663-669.
10. Pendurthi TK, Hoffman JP, Ross E, et al.: Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma. Am Surg 1998;64:686-692.
11. Abrams RA, Grochow LB, Chakravarthy A, et al.: Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: Survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. Int J Radiat Oncol Biol Phys 1999;44:1039-1046.
12. Klinkenbijl JH, Jeekel J, Sahmoud T, et al.: Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776-782; discussion 782-784.
13. Paulino AC: Resected pancreatic cancer treated with adjuvant radiotherapy with or without 5-fluorouracil: Treatment results and patterns of failure. Am J Clin Oncol 1999;22:489-494.
14. Mehta VK, Fisher GA, Ford JM, et al.: Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer. Int J Radiat Oncol Biol Phys 2000;48:1483-1487.
15. Nukui Y, Picozzi VJ, Traverso LW: Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 2000; 179:367-371.
16. Chakravarthy A, Abrams RA, Yeo CJ, et al.: Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: Acceptable toxicity and suggestion of improved 1-year disease-free survival. Int J Radiat Oncol Biol Phys 2000;48:1089-1096.
17. Neoptolemos JP, Dunn JA, Stocken DD, et al.: Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial. Lancet 2001;358:1576-1585.
18. Picozzi VJ, Kozarek RE, Jacobs AD, et al.: Adjuvant therapy for resected pancreas cancer (PC) using alpha-interferon (IFN)-based chemoradiation: Completion of a phase II trial. Proc Am Soc Clin Oncol 2003;22: abstr 1061.
19. Van Laethem JL, Demols A, Gay F, et al.: Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: A phase II study. Int J Radiat Oncol Biol Phys 2003;56:974-980.
20. Neoptolemos JP, Stocken DD, Friess H, et al.: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-1210.
21. Todd KE, Gloor B, Lane JS, et al.: Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamole. J Gastrointest Surg 1998;2:159-166.
22. Neoptolemos JP, Stocken DD, Dunn JA, et al.: Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 2001;234:758-768.
23. Bydder S, Spry N. Chemotherapy for pancreatic cancer. N Engl J Med 2004;350:2713-2715; author reply 2713-2715.
24. Crane CH, Ben-Josef E, Small W Jr: Chemotherapy for pancreatic cancer. N Engl J Med 2004;350:2713-2715; author reply 2713-2715.
25. Morris SL, Beasley M, Leslie M: Chemotherapy for pancreatic cancer. N Engl J Med 2004;350:2713-2715; author reply 2713-2715.
26. Macdonald JS, Smalley SR, Benedetti J, et al.: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-730.
27. Regine WF, Winter KW, Abrans R, et al.: RTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma. J Clin Oncol 2006;24:4007.
28. Hoffman JP, Lipsitz S, Pisansky T, et al.: Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An eastern cooperative oncology group study. J Clin Oncol 1998;16:317-323.
29. Breslin TM, Hess KR, Harbison DB, et al.: Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: Treatment variables and survival duration. Ann Surg Oncol 2001;8:123-132.
30. Evans DB, Rich TA, Byrd DR, et al.: Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 1992;127:1335-1339.
31. Staley CA, Lee JE, Cleary KR, et al.: Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 1996;171:118-124; discussion 124-125.
32. Pisters PW, Abbruzzese JL, Janjan NA, et al.: Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol 1998;16:3843-3850.
33. Moore MJ, Goldstein D, Hamm J, et al.: Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer. A phase III trial of the national cancer institute of Canada clinical trials group [NCIC-CTG]. ASCO Meeting Abstracts 2005; 23.
34. Jaffee EM, Hruban RH, Biedrzycki B, et al.: Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: A phase I trial of safety and immune activation. J Clin Oncol 2001;19:145-156.
35. Laheru D, Yeo C, Biedrzycki B, et al.: A safety and efficacy trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene in combination with adjuvant chemoradiotherapy for the treatment of adenocarcinoma of the pancreas. 2006; In press.